Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lack of association between the TNFAIP3 rs2230926 variant and rheumatoid arthritis-associated lymphoma.

Joint bone spine·2022
Same author

Lymphoma complicating rheumatoid arthritis: results from a French case-control study.

RMD open·2021
Same author

Herpes zoster: Risk and prevention during immunomodulating therapy.

Joint bone spine·2016
Same author

Systemic diseases and biotherapies: understanding, evaluating, and preventing the risk of hepatitis B reactivation.

Joint bone spine·2014
Same author

Abatacept therapy and safety management.

Joint bone spine·2012
Same author

Therapeutic approach to giant cell arteritis.

Joint bone spine·2011
Same journal

Answer to Elbaz et al.

Joint bone spine·2026
Same journal

Greater trochanteric bursal distension with intra-bursal rice bodies: an unusual MRI presentation.

Joint bone spine·2026
Same journal

Evaluating the Impact of a Rheumatologist-led Comorbidity Review in Patients with Inflammatory Arthritis.

Joint bone spine·2026
Same journal

What cumulative glucocorticoid dose should trigger sparing strategies in polymyalgia rheumatica?

Joint bone spine·2026
Same journal

Club Rhumatismes et Inflammation guidelines for anti-interleukin-1 therapy: 2026 update.

Joint bone spine·2026
Same journal

Multimodal imaging evaluation of the entheses in spondyloarthritis.

Joint bone spine·2026
See all related articles

Related Experiment Video

Updated: Jun 8, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

Rheumatoid anemia.

Charles Masson1

  • 1Service de Rhumatologie, pôle Ostéoarticulaire, 4 rue Larrey, CHU d'Angers, Angers 49933 cedex 9, France. ChMasson@chu-angers.fr

Joint Bone Spine
|September 21, 2010
PubMed
Summary
This summary is machine-generated.

Rheumatoid anemia, a type of anemia of chronic disease, is characterized by elevated hepcidin due to interleukin-6 (IL-6). Targeting IL-6 shows promise for managing this condition.

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Related Experiment Videos

Last Updated: Jun 8, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Area of Science:

  • Hematology
  • Immunology
  • Rheumatology

Background:

  • Rheumatoid anemia is a common anemia of chronic disease, distinct from iron deficiency anemia.
  • It presents as normochromic, normocytic (or microcytic), aregenerative anemia with thrombocytosis.
  • Key diagnostic features include normal/low transferrin saturation, normal/high ferritin, and normal soluble transferrin receptor (sTfR).

Purpose of the Study:

  • To review the prevalence and impact of rheumatoid anemia.
  • To describe iron metabolism in the context of rheumatoid anemia.
  • To highlight the roles of hepcidin and interleukin-6 (IL-6) in its pathogenesis.

Main Methods:

  • Literature review of studies on rheumatoid anemia, iron metabolism, transferrin, ferritin, and hepcidin.
  • Analysis of data linking IL-6 to anemia development in chronic disease.
  • Review of recent data on hepcidin levels in rheumatoid arthritis patients.

Main Results:

  • Hepcidin, regulated by IL-6 and hemojuvelin, is central to rheumatoid anemia pathogenesis.
  • IL-6 increases hepcidin production, leading to reduced serum iron and impaired erythropoiesis.
  • Iron deficiency and increased erythropoiesis suppress hepcidin production.

Conclusions:

  • Rheumatoid anemia pathogenesis involves a cascade of IL-6, hepcidin, and iron dysregulation.
  • Optimal control of rheumatoid arthritis disease activity is crucial for managing rheumatoid anemia.
  • IL-6 antagonists represent a promising therapeutic strategy for rheumatoid anemia.